Skip to main content

ULTRALIFE CORP

corporate_fare Company Profile

ULTRALIFE CORP

ULBI·NASDAQ·Manufacturing·CIK 0000875657

Ultralife Corporation provides power solutions and communications and electronics systems to government, defense, and commercial customers globally. The company designs and manufactures power and communications systems, including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom engineered systems related to these product lines. Ultralife sells its products worldwide through original equipment manufacturers ("OEMs"), industrial and defense supply distributors, and directly to U.S. and foreign defense departments. Historically, the company used sub-brands such as Ultralife®, Ultralife Thin Cell®, Ultralife HiRate®, Ultralife & design®, LithiumPower®, LithiumPower & Design®, SMART CIRCUIT®, SMARTCIRCUIT®, SMART CIRCUIT & design®, SODIUMPOWER®, SODIUMPOWER (design)®, WE. ARE. POWER®, AMTI®, ABLE™, ACCUTRONICS™, ACCUPRO™, ENTELLION™, McDowell Research®, SWE DRILL-DATA®, SWE SEASAFE (& DESIGN)®, SWE SEASAFE DIRECT®, SWE SOUTHWEST ELECTRONIC ENERGY CORP®, SWE Southwest Electronic Energy Group®, Excell Battery Group™ and Criterion Gauge™, POW-R BMS®, POW-R-BMS®, POW-R TOTE® and Electrochem®. In October 2025, Ultralife began a rebranding initiative to consolidate all sub-brands under the single Ultralife master brand, de-emphasizing brands like Accutronics, Southwest Electronic Energy, Excell Battery, McDowell Research, and AMTI. The company has sales, operations, and product development facilities in North America, Europe, and Asia.

ULTRALIFE CORP (NASDAQ:ULBI) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 12 items for ULBI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-07, rated 8/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for ULBI spans 10-Q, DEF 14A, 4, 8-K.

Recent high-impact activity:

  • Ultralife Q2 2026: Record Backlog and Margin Expansion Overshadowed by Unremediated Material Weakness
  • Annual Meeting Proxy Details: Missed Executive Bonuses & 40.3% Insider Ownership Confirmed
  • ULTRALIFE Director & 10% Owner Buys $715K in Open Market
  • Ultralife Reports Q1 Net Loss and Revenue Decline Amidst Ongoing Material Weakness in Internal Controls
  • Ultralife Reports Q1 Net Loss and Revenue Decline Amid Operational Challenges; Backlog Hits Record High

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$191.16M
Net Income
-$5.9M
Diluted EPS
-$35.00
Op. Cash Flow
$10.99M
Free Cash Flow
$7.12M
Gross Profit
$46.02M
Operating Income
-$5.9M
Cash & Equivalents
$9.35M
Total Debt
$49.65M
Debt / Equity
0.38×
Net Margin
-3.1%
Shares Outstanding
16.66M sh
Source: 10-K · filed 2026-04-29 · accession 0001437749-26-013737

Short Interest & Short Volume

2.60 days to cover

FINRA reported short interest of 104,662 shares in ULBI as of the September 15, 2026 settlement, a 5.5% decrease from the prior period — about 2.6 days to cover at its recent average daily volume. On October 2, 2026, 41.7% of ULBI volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)104,662 shares as of September 15, 2026
Change vs prior period▼ 5.5%
Days to cover2.60 at avg daily volume of 40,245
Daily short volume (FINRA facilities)41.7% of 10,922 shares on October 2, 2026
5-day average short volume53.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with U →
$6.51
52-week range · as of 2026-08-07 $4.9 – $8.25
Market cap
$108.48M
Volume
19.8K (0.5× avg)
3-mo avg 42.3K
Live data · 2026-10-05 04:25 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed ULBI - Latest Insights

ULBI
Aug 07, 2026, 7:30 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.98
Real-time Price: $6.51 info
Change: +$0.530 (+9%) info
Market Cap: $108.478M info
ULBI
Jun 02, 2026, 1:07 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $7.14
Real-time Price: $6.51 info
Change: -$0.625 (-9%) info
Market Cap: $108.478M info
ULBI
May 26, 2026, 4:18 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $6.86
Real-time Price: $6.51 info
Change: -$0.350 (-5%) info
Market Cap: $108.478M info
ULBI
May 08, 2026, 7:31 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $6.71
Real-time Price: $6.51 info
Change: -$0.1995 (-3%) info
Market Cap: $108.478M info
ULBI
May 08, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.71
Real-time Price: $6.51 info
Change: -$0.1995 (-3%) info
Market Cap: $108.478M info
ULBI
May 08, 2026, 7:07 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $6.71
Real-time Price: $6.51 info
Change: -$0.200 (-3%) info
Market Cap: $108.478M info
ULBI
Mar 23, 2026, 4:01 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $6.55
Real-time Price: $6.51 info
Change: -$0.040 (-0.61%) info
Market Cap: $108.478M info
ULBI
Mar 16, 2026, 7:16 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $7.12
Real-time Price: $6.51 info
Change: -$0.610 (-9%) info
Market Cap: $108.478M info
ULBI
Mar 16, 2026, 4:25 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $7.24
Real-time Price: $6.51 info
Change: -$0.730 (-10%) info
Market Cap: $108.478M info
ULBI
Mar 10, 2026, 6:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $5.73
Real-time Price: $6.51 info
Change: +$0.780 (+14%) info
Market Cap: $108.478M info
ULBI
Mar 10, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.73
Real-time Price: $6.51 info
Change: +$0.780 (+14%) info
Market Cap: $108.478M info
ULBI
Mar 10, 2026, 7:08 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $5.33
Real-time Price: $6.51 info
Change: +$1.18 (+22%) info
Market Cap: $108.478M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets